A chemiluminescent immunoassay for urinary thromboxane B2.
Because of the vasoactive properties of thromboxane A2 and other related prostaglandins, much research has been conducted on drugs which alter their levels. Urinary levels of thromboxane B2 and 2,3-dinor thromboxane B2 (major urinary metabolite of thromboxane B2) are used as an indication of thromboxane production in-vivo. In order to accurately measure urinary TXB2 levels of subjects on investigative drugs which lower TXA2 and subsequently TXB2, a simple and sensitive analytical tool becomes necessary. We have thus developed a non-radioisotopic (chemiluminescent) assay for urinary TXB2. Sensitivity has been demonstrated to 5 pg/ml. The method correlates well with gas chromatography/mass spectrometry (the accepted reference method) even without column chromatographic purification prior to the conduct of the chemiluminescent assay (r = 0.96). In addition, we have demonstrated feasibility for a chemiluminescent assay to measure urinary 2,3-dinor TXB2.
Morello
A
A
Ciba Corning Diagnostics, Inc. E. Walpole, MA 02032.
Chang
S
S
Jacob
A
A
Law
S J
SJ
Stastny
M
M
Martin
L
L
Pamidi
A
A
Kotake
A
A
D000166:Acridines / Q000138:chemical synthesis; D002849:Chromatography, Gas; D003429:Cross Reactions; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D008163:Luminescent Measurements; D013058:Mass Spectrometry; D015233:Models, Statistical; D013929:Thromboxane B2 / Q000031:analogs & derivatives / Q000737:chemistry / Q000652:urine*
D000166:Acridines; D013929:Thromboxane B2; C028965:2,3-dinor-thromboxane B2